세계의 내시경 점막하 박리술 시장 : 적응증, 제품, 최종 사용자, 지역, 국가별 분석, 예측(2025-2035년)

Global Endoscopic submucosal dissection Market, Analysis and Forecast: 2025-2035

Endoscopic submucosal dissection is a minimally invasive surgical technique used to remove tumors or lesions from the gastrointestinal (GI) tract, particularly in the esophagus, stomach, and colon. Unlike traditional surgical methods, endoscopic submucosal dissection allows for the complete resection of tumors, including deeper layers of tissue, using an endoscope. The procedure involves the insertion of a thin, flexible tube with a camera (endoscope) into the patient's digestive tract, where it enables surgeons to locate and visualize abnormal growths or lesions.

During the procedure, the surgeon uses specialized tools to dissect the submucosal layer (the layer of tissue beneath the mucosa, or the innermost lining of the GI tract) and remove the targeted lesion, while preserving the surrounding healthy tissue. endoscopic submucosal dissection is particularly effective for treating early-stage cancers and large, superficial tumors that may not be suitable for other endoscopic methods, such as polypectomy.

One of the primary advantages of endoscopic submucosal dissection is that it allows for precise removal of tumors without the need for more invasive surgeries, thus offering faster recovery times, less pain, and minimal scarring. Additionally, it helps in preserving the function of the GI tract, making it a preferred option for many patients with certain types of cancer or benign lesions. However, the procedure requires high skill and expertise and is typically performed in specialized medical centers.

One of the key drivers of the Endoscopic submucosal dissection market is the increasing prevalence of gastrointestinal (GI) cancers, including esophageal, gastric, and colorectal cancers. These cancers often present as early-stage lesions that are amenable to treatment through endoscopic submucosal dissection, a minimally invasive procedure that allows for the en-bloc resection of tumors, reducing the risk of recurrence and the need for more invasive surgeries.

This rising incidence of GI cancers is attributed to factors such as unhealthy dietary habits, sedentary lifestyles, and an aging population, which have significantly increased the cases related to gastrointestinal diseases. As these diseases are often diagnosed at advanced stages, there is a growing emphasis on early detection and intervention.

The demand for endoscopic submucosal dissection procedures is further bolstered by advancements in endoscopic technology, such as improved imaging systems and electrosurgical tools, which enhance the safety and efficacy of the procedure. Additionally, the preference for minimally invasive treatments, which offer benefits like reduced recovery times and preservation of organ function, is contributing to the market's growth.

In summary, the increasing prevalence of gastrointestinal cancers, coupled with technological advancements in endoscopic procedures and a shift towards minimally invasive treatments, are pivotal factors driving the growth of the Endoscopic submucosal dissection market.

Despite the growth of the Endoscopic submucosal dissection market, several challenges persist. One of the primary challenges is the high level of technical expertise required to perform the procedure successfully. endoscopic submucosal dissection is a complex and delicate procedure that demands specialized skills and extensive experience. The risk of complications, such as bleeding or perforation, is higher compared to other less invasive techniques, and improper execution can lead to poor patient outcomes. As a result, the procedure is generally limited to specialized centers with highly trained endoscopists, restricting its availability and limiting its adoption in regions with fewer trained professionals.

Another challenge is the high cost of the procedure, which involves advanced endoscopic equipment, including specialized knives and electrosurgical tools. The need for sophisticated imaging systems, such as high-definition or high-magnification endoscopes, adds to the cost of endoscopic submucosal dissection. Additionally, the procedure often requires longer hospital stays and follow-up care, further increasing the financial burden on healthcare systems and patients.

Finally, patient selection is also a challenge. While endoscopic submucosal dissection is effective for early-stage gastrointestinal cancers, not all patients are suitable candidates. Factors like the size, location, and depth of the lesion, as well as the patient's overall health, can influence the success of the procedure. These limitations mean that endoscopic submucosal dissection may not be viable for all gastrointestinal tumors, and other treatments may be required, reducing the overall demand for this technique.

The global Endoscopic submucosal dissection market is highly competitive, with major players such as Olympus Corporation, Fujifilm Holdings Corporation, Boston Scientific Corporation, Medtronic, Sumitomo Bakelite Co., Ltd., Creo Medical Group PLC, Hoya Corporation, Conmed Corporation, Steris PLC, MTW Endoskopie Manufaktur, Ovesco Endoscopy AG, Zeon Medical Inc., Micro-Tech Endoscopy, Karl Storz SE & Co. KG, and Cook Medical leading the charge.

These companies play a crucial role in driving innovation and offering a wide range of advanced endoscopic equipment, tools, and technologies that enhance the safety, precision, and effectiveness of endoscopic submucosal dissection procedures. They are actively focusing on technological advancements such as improved imaging systems, electrosurgical tools, and robotics, which have significantly contributed to the growing adoption of endoscopic submucosal dissection as a minimally invasive treatment for gastrointestinal cancers. With ongoing product development and strategic partnerships, these companies are set to maintain their leadership positions in the market and contribute to the continued growth of the endoscopic submucosal dissection industry.

Endoscopic submucosal dissection Market Segmentation:

Segmentation 1: by Product

• Gastroscopes And Colonoscopes
• Knives
• Injection Agents
• Tissue Retractors
• Graspers/Clips
• Other Products

Segmentation 2: by Indication

• Stomach Cancer
• Colon Cancer
• Esophageal Cancer

Segmentation 3: by End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centres
• Other End Users

Segmentation 4: by Region

• North America
• Europe
• Asia-Pacific
• Rest-of-the-World

One of the most significant emerging trends in the global Endoscopic submucosal dissection market is the integration of robotic assistance and artificial intelligence (AI) into endoscopic submucosal dissection procedures. Robotic systems are enhancing the precision and control of surgeons, particularly in complex cases with large or challenging lesions.

These systems provide increased maneuverability and accuracy, allowing for more effective and safer dissections. Additionally, AI technologies are being incorporated to assist in lesion detection, characterization, and real-time guidance during procedures. AI-powered tools help endoscopists identify abnormalities more accurately, potentially reducing the risk of missed diagnoses and improving patient outcomes.

These advancements in robotics and AI are revolutionizing the endoscopic submucosal dissection field by improving precision, minimizing complications, and making the procedure more accessible, ultimately contributing to the continued growth and adoption of endoscopic submucosal dissection in gastrointestinal cancer treatment.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Endoscopic Submucosal Dissection Market: Industry Outlook

• 1.1 Introduction
• 1.2 Market Trends
• 1.3 Regulatory Framework
• 1.4 Patent Analysis
• 1.5 Case Studies
• 1.6 Product Benchmarking
• 1.7 Market Dynamics
  • 1.7.1 Impact Analysis
  • 1.7.2 Market Drivers
  • 1.7.3 Market Challenges
  • 1.7.4 Market Opportunities

2. Global Endoscopic Submucosal Dissection Market (by Product), ($Billion), 2024-2035

• 2.1 Gastroscopes And Colonoscopes
• 2.2 Knives
• 2.3 Injection Agents
• 2.4 Tissue Retractors
• 2.5 Graspers/Clips
• 2.6 Other Products

3. Global Endoscopic Submucosal Dissection Market (by Indication), ($Billion), 2024-2035

• 3.1 Stomach Cancer
• 3.2 Colon Cancer
• 3.3 Esophageal Cancer

4. Global Endoscopic Submucosal Dissection Market (by End User), ($Billion), 2024-2035

• 4.1 Hospitals
• 4.2 Specialty Clinics
• 4.3 Ambulatory Surgical Centres
• 4.4 Other End Users

5. Global Endoscopic Submucosal Dissection Market (by Region), ($Billion), 2024-2035

• 5.1 North America
  • 5.1.1 Key Findings
  • 5.1.2 Market Dynamics
  • 5.1.3 Market Sizing and Forecast
    • 5.1.3.1 North America Endoscopic Submucosal Dissection Market, by Country
      • 5.1.3.1.1 U.S.
      • 5.1.3.1.2 Canada
• 5.2 Europe
  • 5.2.1 Key Findings
  • 5.2.2 Market Dynamics
  • 5.2.3 Market Sizing and Forecast
    • 5.2.3.1 Europe Endoscopic Submucosal Dissection Market, by Country
      • 5.2.3.1.1 Germany
      • 5.2.3.1.2 U.K.
      • 5.2.3.1.3 France
      • 5.2.3.1.4 Italy
      • 5.2.3.1.5 Spain
      • 5.2.3.1.6 Rest of the Europe
• 5.3 Asia Pacific
  • 5.3.1 Key Findings
  • 5.3.2 Market Dynamics
  • 5.3.3 Market Sizing and Forecast
    • 5.3.3.1 Asia Pacific Endoscopic Submucosal Dissection Market, by Country
      • 5.3.3.1.1 China
      • 5.3.3.1.2 Japan
      • 5.3.3.1.3 India
      • 5.3.3.1.4 Australia
      • 5.3.3.1.5 Rest of Asia Pacific
• 5.4 Rest of the World
  • 5.4.1 Key Findings
  • 5.4.2 Market Dynamics
  • 5.4.3 Market Sizing and Forecast

6. Global Endoscopic Submucosal Dissection Market: Competitive Landscape and Company Profiles

• 6.1 Key Strategies and Development
  • 6.1.1 Mergers and Acquisitions
  • 6.1.2 Synergistic Activities
  • 6.1.3 Business Expansions and Funding
  • 6.1.4 Product Launches and Approvals
  • 6.1.5 Other Activities
• 6.2 Company Profiles
  • 6.2.1 Fujifilm Holdings Corporation
    • 6.2.1.1 Overview
    • 6.2.1.2 Top Products / Product Portfolio
    • 6.2.1.3 Top Competitors
    • 6.2.1.4 Target Customers/End-Users
    • 6.2.1.5 Key Personnel
    • 6.2.1.6 Analyst View
  • 6.2.2 Olympus Corporation
    • 6.2.2.1 Overview
    • 6.2.2.2 Top Products / Product Portfolio
    • 6.2.2.3 Top Competitors
    • 6.2.2.4 Target Customers/End-Users
    • 6.2.2.5 Key Personnel
    • 6.2.2.6 Analyst View
  • 6.2.3 Boston Scientific Corporation
    • 6.2.3.1 Overview
    • 6.2.3.2 Top Products / Product Portfolio
    • 6.2.3.3 Top Competitors
    • 6.2.3.4 Target Customers/End-Users
    • 6.2.3.5 Key Personnel
    • 6.2.3.6 Analyst View
  • 6.2.4 Medtronic plc
    • 6.2.4.1 Overview
    • 6.2.4.2 Top Products / Product Portfolio
    • 6.2.4.3 Top Competitors
    • 6.2.4.4 Target Customers/End-Users
    • 6.2.4.5 Key Personnel
    • 6.2.4.6 Analyst View
  • 6.2.5 Sumitomo Bakelite Co., Ltd.
    • 6.2.5.1 Overview
    • 6.2.5.2 Top Products / Product Portfolio
    • 6.2.5.3 Top Competitors
    • 6.2.5.4 Target Customers/End-Users
    • 6.2.5.5 Key Personnel
    • 6.2.5.6 Analyst View
  • 6.2.6 Hoya Corporation
    • 6.2.6.1 Overview
    • 6.2.6.2 Top Products / Product Portfolio
    • 6.2.6.3 Top Competitors
    • 6.2.6.4 Target Customers/End-Users
    • 6.2.6.5 Key Personnel
    • 6.2.6.6 Analyst View
  • 6.2.7 Creo Medical Group PLC
    • 6.2.7.1 Overview
    • 6.2.7.2 Top Products / Product Portfolio
    • 6.2.7.3 Top Competitors
    • 6.2.7.4 Target Customers/End-Users
    • 6.2.7.5 Key Personnel
    • 6.2.7.6 Analyst View
  • 6.2.8 Conmed Corporation
    • 6.2.8.1 Overview
    • 6.2.8.2 Top Products / Product Portfolio
    • 6.2.8.3 Top Competitors
    • 6.2.8.4 Target Customers/End-Users
    • 6.2.8.5 Key Personnel
    • 6.2.8.6 Analyst View
  • 6.2.9 Steris PLC
    • 6.2.9.1 Overview
    • 6.2.9.2 Top Products / Product Portfolio
    • 6.2.9.3 Top Competitors
    • 6.2.9.4 Target Customers/End-Users
    • 6.2.9.5 Key Personnel
    • 6.2.9.6 Analyst View
  • 6.2.10 MTW Endoskopie Manufaktur
    • 6.2.10.1 Overview
    • 6.2.10.2 Top Products / Product Portfolio
    • 6.2.10.3 Top Competitors
    • 6.2.10.4 Target Customers/End-Users
    • 6.2.10.5 Key Personnel
    • 6.2.10.6 Analyst View
  • 6.2.11 Karl Storz SE & Co. KG
    • 6.2.11.1 Overview
    • 6.2.11.2 Top Products / Product Portfolio
    • 6.2.11.3 Top Competitors
    • 6.2.11.4 Target Customers/End-Users
    • 6.2.11.5 Key Personnel
    • 6.2.11.6 Analyst View
  • 6.2.12 Cook Medical
    • 6.2.12.1 Overview
    • 6.2.12.2 Top Products / Product Portfolio
    • 6.2.12.3 Top Competitors
    • 6.2.12.4 Target Customers/End-Users
    • 6.2.12.5 Key Personnel
    • 6.2.12.6 Analyst View
  • 6.2.13 Leo Medical Co., Ltd.
    • 6.2.13.1 Overview
    • 6.2.13.2 Top Products / Product Portfolio
    • 6.2.13.3 Top Competitors
    • 6.2.13.4 Target Customers/End-Users
    • 6.2.13.5 Key Personnel
    • 6.2.13.6 Analyst View
  • 6.2.14 Hangzhou AGS Medical Technological Co., Ltd.
    • 6.2.14.1 Overview
    • 6.2.14.2 Top Products / Product Portfolio
    • 6.2.14.3 Top Competitors
    • 6.2.14.4 Target Customers/End-Users
    • 6.2.14.5 Key Personnel
    • 6.2.14.6 Analyst View
  • 6.2.15 Beijing ZKSK Technology Co., Ltd.
    • 6.2.15.1 Overview
    • 6.2.15.2 Top Products / Product Portfolio
    • 6.2.15.3 Top Competitors
    • 6.2.15.4 Target Customers/End-Users
    • 6.2.15.5 Key Personnel
    • 6.2.15.6 Analyst View

7. Research Methodology